‘Stronger’ Warnings About Suicide Risk With ADHD Drugs in Canada

First Drug for Binge-Eating Disorder Approved
First Drug for Binge-Eating Disorder Approved
Health Canada is issuing "stronger, clearer warnings" to the prescribing information of ADHD drugs amid reports of suicidal behavior.

Prompted by reports of suicidal behavior in patients taking ADHD medications, Health Canada is issuing “stronger, clearer warnings” about the risks associated with the drugs.

The drugs are: Adderall XR, Concerta, Biphentin, Strattera, Intuniv XR, Dexedrine, Ritalin, Ritalin SR, and Vyvanse. They are prescribed to help manage attention deficit hyperactivity disorder, a term used to describe people with poor focus, impulsivity and hyperactivity.

Health Canada said that, overall, the benefits of these drugs in ADHD treatment continue to outweigh the risks.

READ FULL ARTICLE Curated publisher From Toronto Star